PMV Pharmaceuticals (PMVP) Other Accumulated Expenses (2019 - 2022)

PMV Pharmaceuticals (PMVP) has 4 years of Other Accumulated Expenses data on file, last reported at $152000.0 in Q4 2022.

• Quarterly Other Accumulated Expenses rose 58.33% year-over-year to $152000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $152000.0 (up 58.33% YoY) and the FY2022 annual result came in at $152000.0, up 58.33% from the prior year.
• Other Accumulated Expenses grew to $152000.0 in Q4 2022, from $43000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $499000.0 in Q2 2021 to a low of $39000.0 in Q4 2019.
• A 4-year average of $119909.1 and a median of $96000.0 in 2021 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2020 — Other Accumulated Expenses surged 153.85% — and 2022, when it slumped 78.76%.
• Tracing PMVP's Other Accumulated Expenses over 4 years: stood at $39000.0 in 2019, then jumped by 153.85% to $99000.0 in 2020, then fell by 3.03% to $96000.0 in 2021, then soared by 58.33% to $152000.0 in 2022.
• The last three Other Accumulated Expenses figures came in at $152000.0 (Q4 2022), $43000.0 (Q3 2022), and $106000.0 (Q2 2022), per Business Quant data.